BranchLab
Summary active Updated May 13, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
BranchLab is an AI platform that helps pharmaceutical companies commercialize therapies by identifying, activating and optimizing high-intent patient and healthcare professional audiences in near real time, without relying on individual-level health information 12. The company announced a $26 million Series A on May 13, 2026, led by McKesson Ventures with participation from FCA Venture Partners, Sanofi Ventures and AIX Ventures, bringing total funding to $35 million 123. BranchLab states its platform has delivered an average increase of nearly 70% in marketing efficacy across a diverse set of therapeutic areas, and plans to use the capital to expand enterprise deployments and deepen integrations across the healthcare and media ecosystem 12.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-05-13 | Series A | $26M | McKesson Ventures | FCA Venture Partners, Sanofi Ventures, AIX Ventures 123 |
What Investors Say
No independently sourced investor quotes found at this time.
What Founders Say
No independently sourced founder quotes found at this time.
Sources
-
PR Newswire, “BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization,” May 13, 2026. Accessed May 2026. https://www.prnewswire.com/news-releases/branchlab-raises-26m-series-a-led-by-mckesson-ventures-to-bring-ai-to-pharma-commercialization-302770272.html↩↩↩↩
-
BranchLab, “BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization,” May 13, 2026. Accessed May 2026. https://branchlab.com/insights/branchlab-series-a↩↩↩↩
-
Tech Startups, “BranchLab raises $26M to transform pharma commercialization with privacy-first AI,” May 13, 2026. Accessed May 2026. https://techstartups.com/2026/05/13/branchlab-raises-26m-to-transform-pharma-commercialization-with-privacy-first-ai/↩↩